All In Biotech

Drug Trial Radar · NCT05108051

Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir

A Phase 1, Open-Label, Three-Period, Single-center Study to Assess the Pharmacokinetic Interactions Between ZSP1273 and Oseltamivir in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Nov 19, 2020

Primary completion

Mar 17, 2021

Study completion Mar 17, 2021

Sponsor

Sponsor type
Industry
First posted
Nov 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the drug-drug interaction between ZSP1273 and oseltamivir, the pharmacokinetic characteristics and safety of ZSP1273 and oseltamivir in healthy subjects, so as to provide a basis for the design of administration regimen in subsequent clinical trials.

Conditions

  • Drug-drug Interaction

Interventions

  • ZSP1273Drug

    ZSP1273 tablets 600mg administered orally once daily

  • OseltamivirDrug

    Oseltamivir 75mg administered orally twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Plasma pharmacokineticsTime frame: pre-dose and up to 72hours post-dose
  2. Plasma pharmacokineticsTime frame: pre-dose and up to 72hours post-dose
  3. Plasma pharmacokineticsTime frame: pre-dose and up to 72hours post-dose
  4. Plasma pharmacokineticsTime frame: pre-dose and up to 72hours post-dose
  5. Plasma pharmacokineticsTime frame: pre-dose and up to 72hours post-dose
  6. Number of treatment-emergent adverse events (TEAEs) and Serious Adverse Events(SAE)Time frame: up to 37days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Guangdong Provincial Hospital of Chinese Medicine

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.